These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37605756)

  • 1. Sarcopenia Imperils Postoperative Long-Term Survival in HCC Patients with Metabolic Dysfunction-Associated Fatty Liver Disease: A Propensity Score Matching Analysis.
    Kong Q; Yi M; Teng F; Li H; Chen Z
    J Hepatocell Carcinoma; 2023; 10():1367-1377. PubMed ID: 37605756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC.
    Conci S; Cipriani F; Donadon M; Marchitelli I; Ardito F; Famularo S; Perri P; Iaria M; Ansaloni L; Zanello M; La Barba G; Patauner S; Pinotti E; Molfino S; Germani P; Romano M; Sciannamea I; Ferrari C; Manzoni A; Troci A; Fumagalli L; Delvecchio A; Floridi A; Memeo R; Chiarelli M; Crespi M; Zimmitti G; Griseri G; Antonucci A; Zanus G; Tarchi P; Baiocchi GL; Zago M; Frena A; Ercolani G; Jovine E; Maestri M; Valle RD; Grazi GL; Romano F; Giuliante F; Torzilli G; Aldrighetti L; Ruzzenente A;
    Eur J Surg Oncol; 2022 Jan; 48(1):103-112. PubMed ID: 34325939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in the Impact of Metabolic Dysfunction-associated Fatty Liver Disease on the of Patients with Hepatocellular Carcinoma After Radical Resection.
    Huang J; Wei S; Tang Y; Zhang Q; Luo H; Tang Z; Tang Y; Liu H; Huang W; Dong X; Yang J
    J Cancer; 2023; 14(7):1107-1116. PubMed ID: 37215444
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of Metabolic Dysfunction Associated Fatty Liver Disease on the Prognosis of Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma Based on Propensity Score Matching Analysis.
    Xue J; Wang QX; Xiao HM; Shi MJ; Xie YB; Li S; Lin M; Chi XL
    Cancer Manag Res; 2022; 14():2193-2202. PubMed ID: 35859711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with hepatocellular carcinoma after radical resection.
    Xiong KG; Ke KY; Chen LF; Kong JF; Lin TS; Lin QB; Lin S; Zhu YY
    Hepatobiliary Pancreat Dis Int; 2023 Aug; 22(4):366-372. PubMed ID: 35466065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching.
    Wu Z; Tang H; Wang L; Jin X; Lei Z; Yang P; Zhou J
    BMC Surg; 2022 Mar; 22(1):103. PubMed ID: 35313836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic dysfunction-associated fatty liver disease increases the risk of complications after radical resection in patients with hepatocellular carcinoma.
    Xiong KG; Ke KY; Kong JF; Lin TS; Lin QB; Lin S; Zhu YY
    World J Surg Oncol; 2024 May; 22(1):117. PubMed ID: 38698475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC.
    Liu L; Xie S; Teng YX; Deng ZJ; Chen K; Liu HT; Huo RR; Liang XM; Guo PP; Yang DL; Ma L; Xiang BD; Li LQ; Zhong JH
    Front Oncol; 2021; 11():783339. PubMed ID: 35127490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy.
    Chen W; Hu S; Liu Z; Sun Y; Wu J; Shen S; Peng Z
    Hepatol Int; 2023 Apr; 17(2):406-416. PubMed ID: 36645648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of MAFLD on the complications after hepatectomy in patients with HBV-related hepatocellular carcinoma.
    Xiong KG; Lin TS; Kong JF; Lin QB; Chen LF; Ke KY
    Medicine (Baltimore); 2023 Mar; 102(9):e33062. PubMed ID: 36862923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Margin Affects the Long-Term Prognosis of Patients With Hepatocellular Carcinoma Undergoing Radical Hepatectomy Followed by Adjuvant TACE.
    Bai S; Yang P; Liu J; Xue H; Xia Y; Liu F; Yang Z; Zhang L; Wu Y; Shen F; Wang K
    Oncologist; 2023 Aug; 28(8):e633-e644. PubMed ID: 37029989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study.
    Gou XX; Shi HY; Li C; Chen ZL; Ouyang W; Sun LY; Diao YK; Wang MD; Yao LQ; Gu LH; Pawlik TM; Lau WY; Shen F; Xue J; Yang T
    Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):238-249. PubMed ID: 35643251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Imaging-Diagnosed Sarcopenia on Long-term Prognosis After Curative Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Kong Q; Gao Q; Li W; Chen Z
    Acad Radiol; 2024 Apr; 31(4):1272-1283. PubMed ID: 38071101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of menopausal status on the survival and recurrence of sex-classified hepatocellular carcinoma after liver resection: a case-matched study with propensity score matching.
    Zhang W; Liu F; Huang J; Guo X; Dong W; Wei S; Li L; Zhu X; Zhou W; Liu H
    Aging (Albany NY); 2020 Nov; 12(24):25895-25915. PubMed ID: 33232278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Textbook outcomes of hepatocellular carcinoma patients with sarcopenia: A multicenter analysis.
    Wu DH; Liao CY; Wang DF; Huang L; Li G; Chen JZ; Wang L; Lin TS; Lai JL; Zhou SQ; Qiu FN; Zhang ZB; Chen YL; Wang YD; Zheng XC; Tian YF; Chen S
    Eur J Surg Oncol; 2023 Apr; 49(4):802-810. PubMed ID: 36586787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B.
    van Kleef LA; Choi HSJ; Brouwer WP; Hansen BE; Patel K; de Man RA; Janssen HLA; de Knegt RJ; Sonneveld MJ
    JHEP Rep; 2021 Oct; 3(5):100350. PubMed ID: 34557660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy.
    Feng LH; Zhu YY; Zhou JM; Wang M; Xu WQ; Zhang T; Mao AR; Cong WM; Dong H; Wang L
    Front Oncol; 2023; 13():1104492. PubMed ID: 37293583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma.
    Voron T; Tselikas L; Pietrasz D; Pigneur F; Laurent A; Compagnon P; Salloum C; Luciani A; Azoulay D
    Ann Surg; 2015 Jun; 261(6):1173-83. PubMed ID: 24950264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma.
    Shimose S; Hiraoka A; Casadei-Gardini A; Tsutsumi T; Nakano D; Iwamoto H; Tada F; Rimini M; Tanaka M; Torimura T; Suga H; Ohama H; Burgio V; Niizeki T; Moriyama E; Suzuki H; Shirono T; Noda Y; Kamachi N; Nakano M; Kuromatsu R; Koga H; Kawaguchi T
    Hepatol Res; 2023 Feb; 53(2):104-115. PubMed ID: 36149726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.